Medivir AB (publ) (STO:MVIR)
1.936
-0.042 (-2.12%)
Sep 2, 2026, 5:29 PM CET
Medivir AB Revenue
Medivir AB had revenue of 1.20M SEK in the quarter ending June 30, 2026, a decrease of -20.00%. This brings the company's revenue in the last twelve months to 8.71M, up 118.52% year-over-year. In the year 2025, Medivir AB had annual revenue of 8.51M with 144.14% growth.
Revenue (ttm)
8.71M
Revenue Growth
+118.52%
P/S Ratio
140.40
Revenue / Employee
1.45M
Employees
6
Market Cap
1.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.51M | 5.02M | 144.14% |
| Dec 31, 2024 | 3.48M | -4.15M | -54.36% |
| Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
| Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
| Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 424.56M |
| Genovis AB (publ.) | 136.99M |
| AlzeCure Pharma AB | 97.33M |
| Oncopeptides AB | 95.15M |
| BioInvent International AB | 32.51M |
| Vicore Pharma Holding AB | 3.99M |
| Xspray Pharma AB | 2.47M |
| FluoGuide | 404.33K |
Medivir AB News
- 13 days ago - Medivir AB Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - Medivir AB Quarterly report: Q2 2026 - Filings
- 13 days ago - Medivir AB Slides: Q2 2026 - Filings
- 2 months ago - Medivir AB Slides: Company presentation - Filings
- 4 months ago - Medivir AB Earnings Call Transcript: Q1 2026 - Transcripts
- 4 months ago - Medivir AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Medivir AB Slides: Q1 2026 - Filings
- 5 months ago - Medivir AB Slides: FY 2026 - Filings